Stafford, E. G., Riviere, J. E., Xu, X., Kawakami, J., Wyckoff, G. J., & Jaberi-Douraki, M. (2020). Pharmacovigilance in patients with diabetes: A data-driven analysis identifying specific RAS antagonists with adverse pulmonary safety profiles that have implications for COVID-19 morbidity and mortality. J Am Pharm Assoc (2003).

Stafford, Emma G., Jim E. Riviere, Xuan Xu, Jessica Kawakami, Gerald J. Wyckoff, and Majid Jaberi-Douraki. "Pharmacovigilance in Patients With Diabetes: A Data-driven Analysis Identifying Specific RAS Antagonists With Adverse Pulmonary Safety Profiles That Have Implications for COVID-19 Morbidity and Mortality." J Am Pharm Assoc (2003) 2020.

Stafford, Emma G., et al. "Pharmacovigilance in Patients With Diabetes: A Data-driven Analysis Identifying Specific RAS Antagonists With Adverse Pulmonary Safety Profiles That Have Implications for COVID-19 Morbidity and Mortality." J Am Pharm Assoc (2003) 2020.